A phase II trial of imatinib in patients with refractory/relapsed myeloma

Angela Dispenzieri, Morie A. Gertz, Martha Q. Lacy, Susan M. Geyer, Phillip R. Greipp, S. Vincent Rajkumar, Teresa Kimlinger, John A. Lust, Rafael Fonseca, Jacob Allred, Thomas E. Witzig

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of imatinib in patients with refractory/relapsed myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences